Launch of the Africa HealthTech Marketplace

By Crystal Lubbe

November 12, 2024

The article titled “A New Digital Health Platform for Africa” on the Africa CDC website highlights the launch of the Africa HealthTech Marketplace. A new digital health platform designed to transform healthcare across the continent. This initiative aims to address healthcare gaps impacting 600 million Africans without basic medical services.

Launch and Collaboration

This digital health platform was officially launched on October 29, 2024. This initiative is a collaborative effort between the Africa CDC and the Digital Impact Alliance (DIAL).

Purpose and Objectives

The platform showcases accessible digital health solutions for diverse needs across African Union member states. By addressing access, cost, and infrastructure issues, this platform fills a major gap in healthcare delivery.

Features of the Platform

The Africa HealthTech Marketplace provides a comprehensive catalog of trusted tools, products, and resources. By simplifying digital transformation, it equips government technologists, policymakers, and health professionals with the tools needed to evaluate and implement effective digital health solutions in their communities.

Benefits

This platform enhances visibility for African innovators and startups in the health tech sector, allowing users to make informed procurement decisions. Furthermore, it features a space for users to provide comments, questions, feedback, and suggestions regarding the digital solutions available.

Impact and Goals

The Africa HealthTech Marketplace aims to transform healthcare in Africa by enabling providers to access essential tools for improved health outcomes. The platform bridges the gap between innovation and implementation, allowing providers to find and integrate trusted digital health solutions easily.

Stakeholder Engagement

The platform promotes partnerships with stakeholders invested in the African health ecosystem. It aims to build a vibrant community of users who will engage and collaborate within the Africa HealthTech Marketplace, driving meaningful development across the sector.

Transforming Healthcare and Innovation in Africa

The platform showcases accessible digital health solutions for diverse needs across African Union member states. Therefore, it enhances visibility for local innovators, addresses healthcare gaps, and empowers community changemakers to deliver vital services, fostering a vibrant digital health community.

In conclusion, the Africa HealthTech Marketplace represents a significant advancement in Africa CDC’s Digital Transformation Strategy.  Overall, leveraging technology to strengthen public health systems, improve health outcomes, and confront the profound healthcare challenges facing the continent.

Reference url

Recent Posts

access to medicines
         

Quantifying EU Medicine Access Challenges

🔍 Are we creating a healthcare system that truly works for everyone?

Recent findings from EFPIA shed light on alarming inequities in access to medicines across Europe, showing that only 46% of approved drugs are available to patients this year. With significant delays affecting smaller markets and critical cancer treatments, this article explores the systemic barriers at play and innovative solutions proposed to ensure fair access.

Dive into the full article to uncover how we can collectively shape a more equitable healthcare landscape.

#SyenzaNews #healthcare #MarketAccess

UK Medicine Payment Rates
      

Revitalizing Innovation: The Impact of UK Medicine Payment Rates

💡 Are the UK’s medicine payment rates stifling innovation in life sciences?

Recent analysis reveals that the staggering 23.5% payment rate for pharmaceuticals is not just limiting NHS spending but also curtailing R&D investments, delaying new drug launches, and threatening workforce stability. If we can lower these rates to below 10%, we could unleash significant growth and restore the UK’s competitive edge in the global life sciences landscape.

Discover the critical insights and recommendations that could reshape the future of healthcare in the UK.

#SyenzaNews #healthcarepolicy #innovation

Blinatumomab benefit assessment
            

Blinatumomab Benefit Assessment for ALL and Health Economics

🚀 How does a groundbreaking therapy change the landscape of acute lymphoblastic leukemia treatment?

The recent benefit assessment of Blinatumomab by the German Federal Joint Committee reveals critical insights into its potential as a consolidation therapy for adults with Philadelphia chromosome-negative B-cell precursor ALL. With its orphan drug status promising automatic benefits, the article explores the implications of its high cost and economic impacts, shedding light on the balance needed between innovation and sustainability in healthcare.

Jump into the full analysis to understand how this could impact clinical practice and health economics.

#SyenzaNews #HealthEconomics #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.